We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.65B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+22.9%
3 Year Est. Return
+58.88%
5 Year Est. Return
+87.69%
10 Year Est. Return
+260.41%
AUM
$1.37B
AUM Growth
+$72.3M
Cap. Flow
-$8.66M
Cap. Flow %
-0.63%
Top 10 Hldgs %
51.78%
Holding
113
New
11
Increased
31
Reduced
49
Closed
5

Top Buys

Rank Stock Value
1
ACL
Alcon CHF 0.20 PAR VALUE
ACL
+$14.1M
2
IQV icon
IQVIA
IQV
+$2.65M
3
MDT icon
Medtronic
MDT
+$1.89M
4
AMZN icon
Amazon
AMZN
+$1.12M
5
RTO icon
Rentokil
RTO
+$987K

Top Sells

Rank Stock Value
1
ALC icon
Alcon
ALC
+$9.74M
2
NVS icon
Novartis
NVS
+$5.7M
3
MRK icon
Merck
MRK
+$4.64M
4
EXPD icon
Expeditors International
EXPD
+$3.4M
5
STT icon
State Street
STT
+$3.29M

Sector Composition

Rank Sector Weight
1 Technology 29.83%
2 Healthcare 21.57%
3 Consumer Staples 12.98%
4 Industrials 8.61%
5 Financials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
26
Expeditors International
EXPD
$23.2B
$16.7M 1.21%
137,704
-29,916
-18% -$3.4M
SYK icon
27
Stryker
SYK
$129B
$16.1M 1.17%
53,101
-679
-1% -$196K
IQV icon
28
IQVIA
IQV
$38.3B
$16.1M 1.17%
71,639
+13,180
+23% +$2.65M
RTO icon
29
Rentokil
RTO
$12.3B
$15.6M 1.14%
400,655
+25,176
+7% +$987K
MDT icon
30
Medtronic
MDT
$110B
$14.7M 1.07%
166,646
+21,950
+15% +$1.89M
SO icon
31
Southern Company
SO
$107B
$14.1M 1.03%
200,549
-2,504
-1% -$180K
ACL
32
DELISTED
Alcon CHF 0.20 PAR VALUE
ACL
$14.1M 1.02%
+171,476
New +$14.1M
APD icon
33
Air Products & Chemicals
APD
$66.8B
$10.9M 0.79%
36,468
+1,237
+4% +$352K
XOM icon
34
ExxonMobil
XOM
$642B
$9.04M 0.66%
84,290
+101
+0.1% +$11K
T icon
35
AT&T
T
$162B
$7.53M 0.55%
471,874
-20,358
-4% -$347K
ECL icon
36
Ecolab
ECL
$79.8B
$7.21M 0.53%
38,636
+90
+0.2% +$15.5K
MKC icon
37
McCormick & Company Non-Voting
MKC
$14.1B
$6.32M 0.46%
72,397
-600
-0.8% -$53K
NVS icon
38
Novartis
NVS
$293B
$6.18M 0.45%
61,229
-56,952
-48% -$5.7M
WDS icon
39
Woodside Energy
WDS
$43.2B
$5.78M 0.42%
249,178
+16,893
+7% +$387K
STT icon
40
State Street
STT
$50.8B
$5.73M 0.42%
78,252
-45,700
-37% -$3.29M
EMR icon
41
Emerson Electric
EMR
$87.5B
$5.42M 0.39%
59,914
-4,825
-7% -$406K
GPN icon
42
Global Payments
GPN
$24B
$5.39M 0.39%
54,685
+3,560
+7% +$366K
RTX icon
43
RTX Corp
RTX
$301B
$5.21M 0.38%
53,169
-2,902
-5% -$284K
ABT icon
44
Abbott
ABT
$187B
$4.28M 0.31%
39,254
-975
-2% -$104K
SHW icon
45
Sherwin-Williams
SHW
$88.2B
$3.73M 0.27%
14,077
-162
-1% -$38.1K
ABBV icon
46
AbbVie
ABBV
$431B
$3.72M 0.27%
27,575
+225
+0.8% +$33K
INTC icon
47
Intel
INTC
$503B
$3.56M 0.26%
106,358
-20,968
-16% -$658K
JPM icon
48
JPMorgan Chase
JPM
$947B
$3.46M 0.25%
23,793
+627
+3% +$86.2K
BHP icon
49
BHP
BHP
$223B
$3.31M 0.24%
55,369
-680
-1% -$40.5K
MMM icon
50
3M
MMM
$93.2B
$2.79M 0.2%
33,395
-568
-2% -$48.3K

Similar funds

Nichols & Pratt Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, Nichols & Pratt Advisers held 113 positions worth $1.37B, up 5.6% from $1.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Nichols & Pratt Advisers's Q2 2023 filing shows 11 new, 31 increased, 49 reduced and 5 closed positions. Its largest new stake was Alcon CHF 0.20 PAR VALUE: 171,476 shares worth $14.1M. The largest sale was Alcon, an estimated $9.74M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2023 buy was Alcon CHF 0.20 PAR VALUE: 171,476 shares worth $14.1M.
  • Nichols & Pratt Advisers added most to IQVIA in Q2 2023, an estimated $2.65M increase.
  • Nichols & Pratt Advisers's biggest Q2 2023 reduction was Novartis, cutting an estimated $5.7M.
  • Nichols & Pratt Advisers fully exited Alcon in Q2 2023, selling an estimated $9.74M.
  • Nichols & Pratt Advisers's ten largest holdings make up 52% of its $1.37B portfolio in Q2 2023.
  • Nichols & Pratt Advisers opened 11 new positions and closed 5 in Q2 2023.
  • Nichols & Pratt Advisers's portfolio value rose 5.6% quarter-over-quarter to $1.37B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2023, filed 2 Aug 2023.